Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

Gholam, Pierre M.; Flancbaum, Louis; Machan, Jason T.; Charney, Douglas A.; Kotler, Donald P.
February 2007
American Journal of Gastroenterology;Feb2007, Vol. 102 Issue 2, p399
Academic Journal
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has been consistently associated with obesity and insulin resistance. Nonalcoholic steatohepatitis (NASH) is a histological entity within NAFLD that can progress to cirrhosis. The exact prevalence of NASH in severe obesity is unknown. It is unclear whether differences in insulin sensitivity exist among subjects with NASH and simple fatty liver. OBJECTIVE: To evaluate the prevalence and correlates of NASH and liver fibrosis in a racially diverse cohort of severely obese subjects. DESIGN: Ninety-seven subjects were enrolled. Liver biopsies, indirect markers of insulin resistance, metabolic parameters, and liver function tests were obtained. RESULTS: Thirty-six percent of subjects had NASH and 25% had fibrosis. No cirrhosis was diagnosed on histology. Markers of hyperglycemia, insulin resistance, and the metabolic syndrome but not body mass index were associated with the presence of NASH and fibrosis. Elevated transaminase levels correlated strongly with NASH and fibrosis but 46% subjects with NASH had normal transaminases. Subjects with NASH had more severe insulin resistance when compared to those with simple fatty liver. A signal detection model incorporating AST and the presence of diabetes predicted the presence of NASH while another incorporating ALT and HbA1C predicted the presence of fibrosis. CONCLUSIONS: NAFLD is associated with the metabolic syndrome rather than excess adipose tissue in severe obesity. Insulin resistance is higher in subjects with NASH versus those with simple fatty liver. Statistical models incorporating markers of liver injury and hyperglycemia may be useful in predicting the presence of liver pathology in this population.


Related Articles

  • Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. DE LUIS, D. A.; ALLER, R.; IZAOLA, O.; SAGRADO, M. GONZALEZ; CONDE, R.; DE LA FUENTE, B.; CASTRILLON, J. L. PEREZ // European Review for Medical & Pharmacological Sciences;Nov/Dec2009, Vol. 13 Issue 6, p413 

    Background and Objective: Insulin resistance and adipocytokines have been associated with fat liver and non-alcoholic fat liver disease (NAFLD). The aim of this research was to study the influence of insulin resistance and adipocytokines in presurgical morbid obese patients on elevated serum...

  • Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity. Aller, R.; De Luis, D. A.; Izaola, O.; Sagrado, M. Gonz├ílez; Conde, R.; Alvarez, T.; Pacheco, D.; Velasco, M. C. // Nutricion Hospitalaria;jul-ago2010, Vol. 25 Issue 4, p572 

    Background and aims: Some studies have pointed to a role of UCP3 in the regulation of biochemical and fat parameters in overweight patients. The aim of our study was to investigate the influence of -55CT polymorphism of UCP3 gene (rs1800849) on histological changes and insulin resistance in...

  • Surgical treatment of nonalcoholic fatty liver disease in severely obese patients. Vander Naalt, Steven J.; Gurria, Juan P.; Holterman, AiXuan L. // Hepatic Medicine: Evidence & Research;2014, Vol. 6, p103 

    Obesity is a multi-organ system disease with underlying metabolic abnormalities and chronic systemic inflammation. Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of obesity metabolic dysfunction and its associated cardiovascular- and liverrelated morbidities and mortality....

  • Fat Depots and Adipokines in Morbidly Obese Individuals. Nogueira, Janaina; Vestri, Helliner S.; Laracastro, Cristina; Julian, Munoz; Gary, Abrams A.; Garvey, William T. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA464 

    Obesity has been described as a "low-grade" inflammatory condition which is the result of the recruitment of macrophages that infiltrate adipose tissue and influence the secretion of biologically active molecules, collectively named adipokines. Adipokines can act locally, in an autocrine or...

  • Insulin resistance in obese hypertensive Asian Indian subjects. Marita, A R; Desai, A; Mokal, R; Nair, S; Dalal, K P // International Journal of Obesity & Related Metabolic Disorders;May1999, Vol. 23 Issue 5, p445 

    Studies insulin resistance levels in obese Asian Indian subjects who are also hypertensive. Key issues of interest; Analysis of pertinent topics and relevant issues; Implications on the study of obesity.

  • Exercise and Insulin Sensitivity in Obese Men. Venables, Michelle // Sport & Exercise Scientist;Mar2009, Issue 19, p26 

    The article focuses on exercise and insulin sensitivity in obese men in Great Britain. It highlights the increased insulin resistance within the skeletal muscles. It also notes the exercise training programs offered to obese individuals. It is believed that demonstrating such exercise can...

  • Liposuction Lacks Health Benefits.  // Massage & Bodywork;Oct/Nov2004, Vol. 19 Issue 5, p13 

    Determines the health benefits of liposuction. Removal of fat tissue; Examination of the effects of liposuction on obese women in the U.S.; Measurement of blood markers and insulin resistance before surgery.

  • love your liver. Kane, Emily A. // Better Nutrition;Oct2009, Vol. 71 Issue 10, p24 

    The article offers information on the nonalcoholic fatty liver disease (NAFLD) that is stated to be the most common liver disease in the U.S. It reportedly has two stages viz the hepatic steatosis due to insulin resistance and non alcoholic steatotic hepatitis. The liver inflammation leads to...

  • Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease. Tolman, Keith G.; Fonseca, Vivian; Dalpiaz, Anthony; Tan, Meng H. // Diabetes Care;Mar2007, Vol. 30 Issue 3, p734 

    The article presents information on a study that reviewed the spectrum of liver disease found in patients with type 2 diabetes and the management of patients with concurrent diabetes and liver disease. Elevation of serum alanine aminotransferase, while uncommon in apparently normal subjects, is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics